The Musculoskeletal Syndrome of Menopause: Why Bone and Joint Changes Are Finally Getting Clinical Attention

Millions of women experience bone, joint, and connective tissue changes during menopause, yet this cluster of symptoms remains dramatically underrecognized in both mainstream medicine and the supplement industry. Now, a prominent orthopedic surgeon is lending her expertise to change that conversation. Dr. Jocelyn Wittstein, a double board-certified orthopedic surgeon and sports medicine specialist at Duke University, has joined the Scientific Advisory Board of Seen Nutrition, a bone health company founded by two pharmacists and researchers who have personal experience with osteoporosis.

What Is the Musculoskeletal Syndrome of Menopause?

The musculoskeletal syndrome of menopause is a collection of bone, joint, and connective tissue changes that occur during midlife in women. Dr. Wittstein has become one of the foremost clinical authorities on this intersection of menopause and musculoskeletal health in the United States. Her research has focused on injuries and conditions that disproportionately affect women, including frozen shoulder, anterior cruciate ligament (ACL) tears in female athletes, and the musculoskeletal syndrome of menopause itself.

The condition has been largely overlooked despite affecting a significant portion of the female population. Dr. Wittstein co-authored a foundational paper on the musculoskeletal syndrome of menopause that has been cited more than 117 times in scientific literature, and she recently co-authored another paper titled "Critical Implications of Female Bone Metabolism in Orthopedics: State of the Art". Her work has helped establish the scientific foundation for understanding how menopause impacts bone density, joint health, and fracture risk.

Why Is This Condition Being Overlooked?

Despite affecting millions of women, the musculoskeletal syndrome of menopause has remained in the shadows of mainstream medical conversation. Part of the problem is that bone loss and joint changes during menopause are often treated as separate issues rather than as interconnected symptoms of a broader syndrome. The supplement industry, too, has largely failed to address this specific cluster of concerns with evidence-based, food-first approaches.

Dr. Wittstein's appointment to Seen Nutrition's Scientific Advisory Board signals a shift in how the industry and medical community are beginning to approach women's bone health during midlife. With over 136,000 followers on Instagram and recurring features in major publications including CNN, The Washington Post, National Geographic, and AARP, Dr. Wittstein has become a trusted educator for millions of women navigating midlife health.

How to Support Bone Health During Menopause

  • Prioritize Food-First Nutrition: Rather than relying solely on synthetic supplements, focus on whole food sources of calcium, vitamin D, magnesium, and phosphorus. These minerals work together naturally in foods like dairy products, leafy greens, nuts, seeds, and mushrooms to support bone density and joint health.
  • Understand Your Bone Density Status: Work with your healthcare provider to assess your bone health through appropriate screening. Knowing your baseline bone density can help you and your doctor develop a personalized prevention strategy before significant bone loss occurs.
  • Address Joint and Connective Tissue Health: Recognize that bone health during menopause is interconnected with joint and connective tissue changes. Incorporate movement, strength training, and flexibility work into your routine to support overall musculoskeletal health, not just bone density alone.

Seen Nutrition was co-founded by Dr. Jennifer Han, PharmD, and Dr. Adrienne Bitar, PhD, both of whom have personal experiences with osteoporosis. The company created the first patented calcium chew made from just four real food ingredients: milk, dates, almonds, and mushrooms. This product delivers highly bioavailable calcium alongside vitamin D, magnesium, phosphorus, and other minerals naturally present in these foods.

"Bone and joint health are among the most overlooked consequences of menopause, and we are finally seeing that conversation change. Seen Nutrition is exactly the kind of company this moment needs, one that starts with real food, real science, and real respect for what women's bodies require. I'm proud to lend my expertise to help more women understand that protecting their bones starts long before they break," said Dr. Jocelyn Wittstein.

Dr. Jocelyn Wittstein, MD, Associate Professor of Orthopaedic Surgery at Duke University School of Medicine

Dr. Wittstein's clinical perspective will guide Seen Nutrition's scientific direction and help validate its food-first approach to bone health. Her appointment also underscores a broader recognition that bone health during menopause requires specialized attention and evidence-based strategies tailored to women's unique physiology.

The timing of this collaboration is significant. Dr. Wittstein joined the Milken Institute Women's Health Network in 2025, chaired by Dr. Jill Biden, and serves on the Scientific Medical Advisory Committee for the Bone Health and Osteoporosis Foundation. These roles position her at the forefront of efforts to elevate women's bone health as a public health priority.

"We founded Seen Nutrition because we knew firsthand the struggle to find high-quality food-first supplements for osteoporosis. Dr. Wittstein brings the clinical credibility, the research depth, and the patient advocacy voice that lines up with everything Seen stands for. We are beyond honored to have her with us," explained Dr. Jennifer Han.

Dr. Jennifer Han, PharmD, Co-founder of Seen Nutrition

As awareness of the musculoskeletal syndrome of menopause grows, women and their healthcare providers are beginning to recognize that bone health during midlife requires a comprehensive approach. This includes understanding how hormonal changes affect not just bone density but also joint integrity and connective tissue resilience. The involvement of leading clinical experts like Dr. Wittstein signals that this conversation is moving from the margins to the mainstream of women's health.